H. S. Semiz Et Al. , "cERBB-2/HER-2neu overexpression and its prognostic significance in uterine carcinosarcoma," ESMO Targeted Anticancer Therapies Congress (TAT) , vol.33, ELECTR NETWORK, 2022
Semiz, H. S. Et Al. 2022. cERBB-2/HER-2neu overexpression and its prognostic significance in uterine carcinosarcoma. ESMO Targeted Anticancer Therapies Congress (TAT) , (ELECTR NETWORK).
Semiz, H. S., Pala, E. E., Can, B., Atag, E., Gungor, H., Ellidokuz, H., ... Sanci, M.(2022). cERBB-2/HER-2neu overexpression and its prognostic significance in uterine carcinosarcoma . ESMO Targeted Anticancer Therapies Congress (TAT), ELECTR NETWORK
Semiz, HÜSEYİN Et Al. "cERBB-2/HER-2neu overexpression and its prognostic significance in uterine carcinosarcoma," ESMO Targeted Anticancer Therapies Congress (TAT), ELECTR NETWORK, 2022
Semiz, HÜSEYİN S. Et Al. "cERBB-2/HER-2neu overexpression and its prognostic significance in uterine carcinosarcoma." ESMO Targeted Anticancer Therapies Congress (TAT) , ELECTR NETWORK, 2022
Semiz, H. S. Et Al. (2022) . "cERBB-2/HER-2neu overexpression and its prognostic significance in uterine carcinosarcoma." ESMO Targeted Anticancer Therapies Congress (TAT) , ELECTR NETWORK.
@conferencepaper{conferencepaper, author={HÜSEYİN SALİH SEMİZ Et Al. }, title={cERBB-2/HER-2neu overexpression and its prognostic significance in uterine carcinosarcoma}, congress name={ESMO Targeted Anticancer Therapies Congress (TAT)}, city={}, country={ELECTR NETWORK}, year={2022}}